FundingWatcher
Home / Investors / Biotech investors / Biotech investors in Belgium

Biotech investors in Belgium

Updated 16 Nov 2026

Reset

Venture funds

2 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Hummingbird Ventures
Hummingbird Ventures backs outlier founders globally, recently investing in Etched and Lovable.
Brussels, Belgium
Artificial intelligence, Biotech Seed, Early stage venture 28% 3
2 Astanor Ventures
Astanor Ventures backs entrepreneurs regenerating food, the blue ocean economy and agriculture, with recent companies BioFluff and Standing Ovation.
Luxembourg, Belgium
Artificial intelligence, Biotech Seed, Early stage venture, Late stage venture 55% 2

Table 1. Biotech investors in Belgium: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in Belgium
One-time CSV
  • 20 firms, 20 with a website
  • 12 firm email addresses
  • 9 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-belgium.csv20 rows × 15 columns
InvestorTypeLocationEmailPhone
GimvPrivate equity firmAntwerp, Belgium•••@gimv.com+32 3 •••
Meusinvest (Noshaq)Venture capital firmLiège, Belgium•••@meusinvest.be+32 (0•••
Hummingbird VenturesVenture capital firmBrussels, Belgium•••@hummingbird.vc+44792•••
EIT Digital AcceleratorStartup acceleratorBrussels, Belgium•••@eitdigital.eu
Bioqube VenturesVenture capital firmHasselt, Belgium•••@bioqubeventures.com
PMVGovernment investment officeBrussels, Belgium•••@pmv.eu02 229•••
Capricorn PartnersVenture capital firmLeuven, Belgium•••@capricorn.be+32 (0•••
Limburgse Reconversie MaatschappijPrivate equity firmHasselt, Belgium•••@lrm.be+32 11•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

20
Investors
12
With email
9
With phone
11
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in Belgium

20 of 20, most investments first
20 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 European Innovation Council Startup accelerator Brussels, Belgium Hardware, Health care Onego Bio, Quantrol Ox, Cellbox Solutions 17 1,271 921 48 In the CSV
2 EIC Accelerator Startup accelerator Brussels, Belgium Health care, Biotech Millow.co, D-CRBN, Omegga GmbH 7 543 517 11 In the CSV
3 European Commission Government investment office Brussels, Belgium Health care, Artificial intelligence Healthplus.ai, NVision Quantum Technologies, Geopyörä Oy 6 296 204 47 +32 2 ••• In the CSV
4 Gimv Private equity firm, Venture capital firm Antwerp, Belgium Health care, Biotech SynOx Therapeutics, Kivu Bioscience, Onera Health 193 63 64 •••@gimv.com +32 3 ••• In the CSV
5 Astanor Ventures Venture capital firm Luxembourg, Belgium Artificial intelligence, Biotech BioFluff, Standing Ovation 2 75 41 8 In the CSV
6 Meusinvest (Noshaq) Venture capital firm Liège, Belgium Health care, Biotech Amyl Therapeutics 1 74 7 8 •••@meusinvest.be +32 (0••• In the CSV
7 Hummingbird Ventures Venture capital firm Brussels, Belgium Artificial intelligence, Biotech Basecamp Research, Etched, Lovable 6 141 39 16 •••@hummingbird.vc +44792••• In the CSV
8 EIT Digital Accelerator Startup accelerator Brussels, Belgium Hardware, Artificial intelligence Cleafy 1 234 6 49 •••@eitdigital.eu In the CSV
9 Bioqube Ventures Venture capital firm Hasselt, Belgium Biotech, Health care Commit Biologics, SynOx Therapeutics, CatalYm 17 6 1 •••@bioqubeventures.com In the CSV
10 PMV Government investment office, Venture capital firm Brussels, Belgium Hardware, Health care Dockflow 1 146 34 24 •••@pmv.eu 02 229••• In the CSV
11 Capricorn Partners Venture capital firm Leuven, Belgium Health care, Artificial intelligence Gradyent, Minze Health, Thryve 118 39 32 •••@capricorn.be +32 (0••• In the CSV
12 Eurostars Government investment office Brussels, Belgium Health care, Biotech Alithea Genomics 1 111 79 12 In the CSV
13 Limburgse Reconversie Maatschappij Private equity firm, Venture capital firm Hasselt, Belgium Commerce, Education Hyperfox 1 94 13 17 •••@lrm.be +32 11••• In the CSV
14 Qbic Fund Micro VC fund, Venture capital firm Ghent, Belgium Hardware, Biotech Swave Photonics, Weavely, Flindr Therapeutics 61 18 11 •••@qbic.fund In the CSV
15 Korys Family office Halle, Belgium Energy, Artificial intelligence Greenely, OroraTech, Eneida 44 20 11 •••@korys.be +32 2 ••• In the CSV
16 V-Bio Ventures Venture capital firm Ghent, Belgium Biotech, Health care Augustine Therapeutics, Flindr Therapeutics 43 16 3 •••@v-bio.ventures In the CSV
17 Gemma Frisius Fund Micro VC fund, Venture capital firm Leuven, Belgium Biotech, Health care DName-iT, ArtiQ, Porphyrio 40 5 7 In the CSV
18 Sambrinvest Venture capital firm Gosselies, Belgium Biotech, Fintech Amyl Therapeutics 1 39 4 3 In the CSV
19 UCB Ventures Corporate venture arm Brussels, Belgium Biotech, Health care EsoBiotec, Walden Biosciences 19 8 4 In the CSV
20 Cascara Ventures Venture capital firm Brussels, Belgium Biotech, Health care microDimensions, Meidrix Biomedicals 13 1 2 •••@cascaraventures.com +32 47••• In the CSV

Table 2. Biotech investors in Belgium: the first 20 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 20.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 European Innovation Council Brussels, Belgium 17 106 Onego Bio, Quantrol Ox, Cellbox Solutions
2 EIC Accelerator Brussels, Belgium 7 36 Millow.co, D-CRBN, Omegga GmbH
3 Hummingbird Ventures Brussels, Belgium 6 22 Basecamp Research, Etched, Lovable
4 European Commission Brussels, Belgium 6 29 Healthplus.ai, NVision Quantum Technologies, Geopyörä Oy
5 Astanor Ventures Luxembourg, Belgium 2 15 BioFluff, Standing Ovation
6 Limburgse Reconversie Maatschappij Hasselt, Belgium 1 11 Hyperfox
7 Meusinvest (Noshaq) Liège, Belgium 1 11 Amyl Therapeutics
8 Sambrinvest Gosselies, Belgium 1 8 Amyl Therapeutics
9 EIT Digital Accelerator Brussels, Belgium 1 48 Cleafy
10 Eurostars Brussels, Belgium 1 6 Alithea Genomics
11 PMV Brussels, Belgium 1 29 Dockflow

Table 3. Biotech investors in Belgium: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Onego Bio Onego Bio produces egg protein through fermentation as a food ingredient. Biotech Helsinki, Finland Series B $28.0M 2026-10-26 $100.6M European Innovation Council 11 to 50 2022
Quantrol Ox QuantrolOx builds machine learning control software that tunes and stabilizes qubits for quantum technologies. Artificial intelligence Espoo, Finland Series A $13.5M 2026-10-22 $21.5M European Innovation Council 11 to 50 2021
Cellbox Solutions Cellbox Solutions provides logistics solutions for the global biomedical industry. Biotech Cologne, Germany Series A $1.7M 2026-10-20 $15.3M European Innovation Council 11 to 50 2017
UniSieve UniSieve provides molecular separation membrane solutions for cleantech applications. Energy Zürich, Switzerland Series A $9.0M 2026-10-08 $19.7M European Innovation Council 11 to 50 2018
Basecamp Research Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. Artificial intelligence London, United Kingdom Series C $140.0M 2026-09-23 $219.9M Hummingbird Ventures 51 to 100 2019
Treble Treble develops acoustic simulation technology for designing sound in architecture, audio, robotics, automotive, XR, and gaming. Artificial intelligence Reykjavík, Iceland Series A $18.0M 2026-09-17 $40.3M European Innovation Council 11 to 50 2019
Healthplus.ai Healthplus.ai uses AI to predict post-operative infection risks for surgical patients. Artificial intelligence Amsterdam, The Netherlands Seed $3.8M 2026-09-03 $8.9M European Commission 11 to 50 2017
BioFluff BioFluff creates plant-based fur, shearling, and plush for the fashion, interior, and toy industries. Biotech Paris, France Seed $2.5M 2026-09-02 $3.2M Astanor Ventures 1 to 10 2022
Amyl Therapeutics Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. Biotech Liège, Belgium Series A $9.6M 2026-09-01 $44.0M Meusinvest (Noshaq), Sambrinvest 1 to 10 2020
Etched Etched designs and manufactures AI chips and hardware systems for inference workloads. Artificial intelligence San Jose, United States Series D $700.0M 2026-08-18 $1.6B Hummingbird Ventures 251 to 500 2022

Table 4. Biotech investors in Belgium: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 225 64%
Health care 102 29%
Hardware 92 26%
Artificial intelligence 86 25%
Biotech 75 21%
Energy 23 7%
Commerce 15 4%
Fintech 13 4%
Education 12 3%
Cybersecurity 12 3%

Table 5. Biotech investors in Belgium: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Biotech investors in Belgium by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Brussels 9 45%
Hasselt 2 10%
Leuven 2 10%
Ghent 2 10%
Antwerp 1 5%
Luxembourg 1 5%
Liège 1 5%
Halle 1 5%
Gosselies 1 5%

Table 7. Biotech investors in Belgium by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2010s 9 45%
2000s 1 5%
1990s 3 15%
1980s 4 20%
1950s 3 15%

Table 8. Biotech investors in Belgium by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in Belgium are on the list?
20, in the file dated 16 November 2026. 11 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
12 of the 20 carry an email address in the download and 9 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 20 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 20 rows, 12 firm email addresses and 9 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 10 of the 12 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in Belgium: 20 rows, CSV, $29 one-time.

At once: the CSV with 20 rows, 12 firm email addresses and 9 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 10 of the 12 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Other portfolio sectors in Belgium

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 20 biotech investors in Belgium, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/belgium/